Our own study with a bladder cancer cell line (J82) showed that rictor gene silencing reduced Rac1-GTP levels to 60.2% of rictor-expressing cells, suggesting that Rac1 may be a major target of mTORC2 in bladder cancer [77]. This evidence concerns the gene RICTOR and urinary bladder cancer.